Middle East Biobanks Market Size, Share & Trends Analysis Report By Product & Services, By Biospecimen (Human Tissues, Human Organs), By Biobanks (Real/Physical Biobanks, Virtual Biobanks), By Application, By Country, And Segment Forecasts, 2025 - 2033
Description
Middle East Biobanks Market Summary
The Middle East biobanks market size was estimated at USD 0.884 billion in 2024 and is projected to reach USD 1.52 billion by 2033, growing at a CAGR of 6.34% from 2025 to 2033. This growth is driven by rising investments in precision medicine, increasing prevalence of chronic and genetic diseases, and government-led initiatives to strengthen healthcare infrastructure. Moreover, the region’s growing focus on genomic research, personalized therapies, and collaborations with international biobanking networks further accelerates market expansion.
Growth of Personalized Medicine and Genomics
The increasing adoption of personalized medicine and genomic research is a major factor driving the biobanks market in the Middle East. Precision medicine requires access to high-quality, patient-specific biological samples and corresponding clinical data to develop therapies tailored to individual genetic profiles. Biobanks are critical repositories that store these samples, enabling researchers and healthcare providers to study disease mechanisms, identify biomarkers, and design effective, targeted treatment strategies. The demand in the Middle East is particularly strong due to unique genetic variations and the high prevalence of inherited disorders, making region-specific biobank resources essential for therapeutic development and clinical research.
Middle East Biobanks Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the Middle East biobanks market report based on product & services, biospecimen, biobanks, application, and country.
The Middle East biobanks market size was estimated at USD 0.884 billion in 2024 and is projected to reach USD 1.52 billion by 2033, growing at a CAGR of 6.34% from 2025 to 2033. This growth is driven by rising investments in precision medicine, increasing prevalence of chronic and genetic diseases, and government-led initiatives to strengthen healthcare infrastructure. Moreover, the region’s growing focus on genomic research, personalized therapies, and collaborations with international biobanking networks further accelerates market expansion.
Growth of Personalized Medicine and Genomics
The increasing adoption of personalized medicine and genomic research is a major factor driving the biobanks market in the Middle East. Precision medicine requires access to high-quality, patient-specific biological samples and corresponding clinical data to develop therapies tailored to individual genetic profiles. Biobanks are critical repositories that store these samples, enabling researchers and healthcare providers to study disease mechanisms, identify biomarkers, and design effective, targeted treatment strategies. The demand in the Middle East is particularly strong due to unique genetic variations and the high prevalence of inherited disorders, making region-specific biobank resources essential for therapeutic development and clinical research.
Middle East Biobanks Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the Middle East biobanks market report based on product & services, biospecimen, biobanks, application, and country.
- Product & Services Outlook (Revenue, USD Million, 2021 - 2033)
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Biobanking Consumables
- Laboratory Information Management Systems
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Biospecimen Outlook (Revenue, USD Million, 2021 - 2033)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Biobanks Outlook (Revenue, USD Million, 2021 - 2033)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Country Outlook (Revenue, USD Million, 2021 - 2033)
- Middle East
- Saudi Arabia
- UAE
- Kuwait
- Qatar
- Oman
- Rest of Middle East
Table of Contents
90 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product & Services
- 1.2.2. Biospecimen
- 1.2.3. Biobanks
- 1.2.4. Application
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
- Chapter 3. Middle East Biobanks Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Growth of personalized medicine and genomics
- 3.2.1.2. Increasing R&D in biotechnology and pharmaceuticals
- 3.2.2. Market restraint analysis
- 3.2.2.1. Challenges in sharing biobanking data & limited access to biospecimens
- 3.2.2.2. Sustainability challenges for biobanks
- 3.2.2.3. Other challenges in biobanking specimens for research
- 3.3. Middle East Biobanks Market Analysis Tools
- 3.3.1. Industry Analysis – Porter’s
- 3.3.2. PESTEL Analysis
- Chapter 4. Middle East Biobanks Market: Product & Services Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Product & Services Market Share, 2024 & 2033
- 4.3. Product
- 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 4.4.1. Biobank Equipment
- 4.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 4.4.1.2. Temperature Control Systems
- 4.4.1.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 4.4.1.2.2. Freezers & Refrigerators
- 4.4.1.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 4.4.1.2.3. Cryogenic Storage Systems
- 4.4.1.2.4. Market estimates and forecasts 2021 to 2033 (USD Million)
- 4.4.1.2.5. Thawing Equipment
- 4.4.1.2.6. Market estimates and forecasts 2021 to 2033 (USD Million)
- 4.4.1.3. Incubators & Centrifuges
- 4.4.1.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 4.4.1.4. Alarms & Monitoring Systems
- 4.4.1.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 4.4.1.5. Accessories & Other Equipment
- 4.4.1.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 4.4.2. Biobanking Consumables
- 4.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 4.4.3. Laboratory Information Management Systems
- 4.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 4.5. Services
- 4.6. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 4.6.1. Biobanking & repository
- 4.6.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 4.6.2. Lab processing
- 4.6.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 4.6.3. Qualification/ Validation
- 4.6.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 4.6.4. Cold Chain Logistics
- 4.6.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 4.6.5. Other Services
- 4.6.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- Chapter 5. Middle East Biobanks Market: Biospecimen Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Biospecimen Market Share, 2024 & 2033
- 5.3. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 5.3.1. Human Tissues
- 5.3.1.1. Market estimates and forecasts 2021 to 2033 (USD million)
- 5.3.2. Human Organs
- 5.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 5.3.3. Stem Cells
- 5.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 5.3.3.2. Adult Stem Cells
- 5.3.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 5.3.3.3. Embryonic Stem Cells
- 5.3.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 5.3.3.4. IPS Cells
- 5.3.3.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 5.3.3.5. Other Stem Cells
- 5.3.3.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 5.3.4. Other biospecimens
- 5.3.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- Chapter 6. Middle East Biobanks Market: Biobanks Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Biobanks Market Share, 2024 & 2033
- 6.3. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 6.3.1. Physical/Real biobanks
- 6.3.1.1. Market estimates and forecasts 2021 to 2033 (USD million)
- 6.3.1.2. Tissue Biobanks
- 6.3.1.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 6.3.1.3. Population based biobanks
- 6.3.1.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 6.3.1.4. Genetic (DNA/RNA)
- 6.3.1.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 6.3.1.5. Disease based biobanks
- 6.3.1.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 6.3.2. Virtual biobanks
- 6.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- Chapter 7. Middle East Biobanks Market: Application Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Application Market Share, 2024 & 2033
- 7.3. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 7.3.1. Therapeutics
- 7.3.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 7.3.2. Drug discovery & clinical research
- 7.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 7.3.3. Clinical Diagnostics
- 7.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 7.3.4. Other Applications
- 7.3.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- Chapter 8. Middle East Biobanks Market: Regional Estimates & Trend Analysis
- 8.1. Country Market Dashboard
- 8.2. Country Market Share Analysis, 2024 & 2033
- 8.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
- 8.4. Middle East
- 8.4.1. Saudi Arabia
- 8.4.1.1. Key country dynamics
- 8.4.1.2. Regulatory framework/ reimbursement structure
- 8.4.1.3. Competitive scenario
- 8.4.1.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
- 8.4.2. UAE
- 8.4.2.1. Key country dynamics
- 8.4.2.2. Regulatory framework/ reimbursement structure
- 8.4.2.3. Competitive scenario
- 8.4.2.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
- 8.4.3. Kuwait
- 8.4.3.1. Key country dynamics
- 8.4.3.2. Regulatory framework/ reimbursement structure
- 8.4.3.3. Competitive scenario
- 8.4.3.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
- 8.4.4. Qatar
- 8.4.4.1. Key country dynamics
- 8.4.4.2. Regulatory framework/ reimbursement structure
- 8.4.4.3. Competitive scenario
- 8.4.4.4. Qatar market estimates and forecasts 2021 to 2033 (USD Million)
- 8.4.5. Oman
- 8.4.5.1. Key country dynamics
- 8.4.5.2. Regulatory framework/ reimbursement structure
- 8.4.5.3. Competitive scenario
- 8.4.5.4. Oman market estimates and forecasts 2021 to 2033 (USD Million)
- 8.4.6. Rest of Middle East
- 8.4.6.1. Key country dynamics
- 8.4.6.2. Regulatory framework/ reimbursement structure
- 8.4.6.3. Competitive scenario
- 8.4.6.4. Rest of Middle East market estimates and forecasts 2021 to 2033 (USD Million)
- Chapter 9. Competitive Landscape
- 9.1. Company/Competition Categorization
- 9.2. Strategy Mapping
- 9.3. Company Market Position Analysis, 2024
- 9.4. Company Profiles/Listing
- 9.4.1. Thermo Fisher Scientific Inc.
- 9.4.1.1. Company overview
- 9.4.1.2. Financial performance
- 9.4.1.3. Product benchmarking
- 9.4.1.4. Strategic initiatives
- 9.4.2. Merck KGaA
- 9.4.2.1. Company overview
- 9.4.2.2. Financial performance
- 9.4.2.3. Product benchmarking
- 9.4.2.4. Strategic initiatives
- 9.4.3. Qiagen
- 9.4.3.1. Company overview
- 9.4.3.2. Financial performance
- 9.4.3.3. Product benchmarking
- 9.4.3.4. Strategic initiatives
- 9.4.4. Danaher Corporation
- 9.4.4.1. Company overview
- 9.4.4.2. Financial performance
- 9.4.4.3. Product benchmarking
- 9.4.4.4. Strategic initiatives
- 9.4.5. Becton, Dickinson, and Company (BD)
- 9.4.5.1. Company overview
- 9.4.5.2. Financial performance
- 9.4.5.3. Product benchmarking
- 9.4.5.4. Strategic initiatives
- 9.4.6. Taylor-Wharton
- 9.4.6.1. Company overview
- 9.4.6.2. Financial performance
- 9.4.6.3. Product benchmarking
- 9.4.6.4. Strategic initiatives
- 9.4.7. Charles River Laboratories
- 9.4.7.1. Company overview
- 9.4.7.2. Financial performance
- 9.4.7.3. Product benchmarking
- 9.4.7.4. Strategic initiatives
- 9.4.8. Lonza
- 9.4.8.1. Company overview
- 9.4.8.2. Financial performance
- 9.4.8.3. Product benchmarking
- 9.4.8.4. Strategic initiatives
- 9.4.9. Stemcell Technologies
- 9.4.9.1. Company overview
- 9.4.9.2. Financial performance
- 9.4.9.3. Product benchmarking
- 9.4.9.4. Strategic initiatives
- 9.4.10. Biovault Family
- 9.4.10.1. Company overview
- 9.4.10.2. Financial performance
- 9.4.10.3. Product benchmarking
- 9.4.10.4. Strategic initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.